| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 526.52M | $ 523.85M | $ 509.79M | $ 489.74M | $ 470.25M |
| Gross Profit | $ 94.28M | $ 88.37M | $ 94.05M | $ 78.92M | $ 83.84M |
| Operating Income | $ 50.49M | $ 58.56M | $ 54.64M | $ 41.52M | $ 45.26M |
| EBITDA | $ 71.12M | $ 73.51M | $ 70.42M | $ 58.69M | $ 63.78M |
| Net Income | $ 29.67M | $ 31.40M | $ 36.67M | $ 19.45M | $ 19.73M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 22.70M | $ 19.16M | $ 15.12M | $ 15.43M | $ 17.70M |
| Total Assets | $ 584.01M | $ 590.41M | $ 586.39M | $ 578.35M | $ 580.85M |
| Total Debt | $ 164.02M | $ 180.14M | $ 215.38M | $ 222.39M | $ 250.26M |
| Net Debt | $ 141.32M | $ 160.99M | $ 200.26M | $ 206.96M | $ 232.56M |
| Total Liabilities | $ 311.80M | $ 332.67M | $ 356.59M | $ 389.40M | $ 419.85M |
| Stockholders' Equity | $ 265.99M | $ 251.99M | $ 224.81M | $ 184.26M | $ 156.45M |
| Cash Flow | |||||
| Free Cash Flow | $ 22.29M | $ 43.36M | $ 14.21M | $ 14.74M | $ 23.04M |
| Operating Cash Flow | $ 37.03M | $ 56.39M | $ 24.79M | $ 24.96M | $ 36.58M |
| Investing Cash Flow | $ -2.23M | $ -6.39M | $ -6.65M | $ -3.86M | $ -10.22M |
| Financing Cash Flow | $ -31.25M | $ -45.96M | $ -18.45M | $ -23.38M | $ -22.46M |
Core Laboratories N.V. (CH:CEI)
:CEI
